Equigerminal has 2 patent families that complement each other:

• Viral Peptides -  WO2015094001A1 protects viral peptides for diagnosis and therapeutics purposes of the New Equine Virus (NEV).
• Antiviral Composition - WO2016195522A2 protects a class of antivirals  to treat viral infections. 

 With 10 international patent processes and 1 biological patent deposit. 

• Viral Peptides - EP3083659B- European Patent 🇪🇺
• Viral Peptides - GB2526222B - United Kingdom  🇬🇧
• Antiviral Composition - GB2544439B - United Kingdom  🇬🇧
• Antiviral Composition - AU2017271995B  - Australia  🇦🇺